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ABSTRACT :  
 
Dendritic cells (DC) control T cell-based immunity. To do so they need to mature and migrate 
to sites of T cell priming. We have previously shown that cognate interactions of human 
CD4+ T cells with DC induce DC maturation. We show here that CC chemokines produced 
during antigen-specific T-DC interactions also induce strong morphological modifications 
and migration of immature DC. These modifications are required for efficient T cell 
activation. Moreover, we show that CC chemokines produced during antigen-specific DC-T 
cell interactions  induce the dissolution of structures involved in cell motility and present on 
immature DC, i.e. podosomes. We thus propose a model in which chemokines secreted during 
Ag-specific contact between T cells and DC induce disassembly of interacting and 
neighboring immature DC podosomes, leading to recruitment of more immature DC towards 
sites of antigenic stimulation and to amplification of T cell responses. 
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INTRODUCTION  
Dendritic cells (DC) are professional antigen presenting cells with the unique property of 
inducing priming and differentiation of naïve CD4+ and CD8+ T cells into helper and 
cytotoxic effectors, respectively. Their efficiency is due to their unique ability to process 
antigen, express costimulatory molecules, secrete cytokines and migrate to the appropriate 
sites, in tissues or lymphoid organs, to prime T cells 1. 
CD4+ helper T cells have been shown to promote the quality of T cell responses 2,3. There is 
ample evidence that this helper activity is due to the ability of CD4+ T cells to act directly on 
DC in an antigen-dependent manner. Indeed, experiments conducted both in murine and 
human models have shown that interaction between CD40 and CD40L 4-7, expressed 
respectively by DC and activated T cells, as well as T cell-derived cytokines such as IFN-γ 
and TNF-α modify the DC properties by inducing expression of costimulatory molecules and 
IL-12 8-10. This T cell-induced modification of DC has been called “education” 3 or 
“licensing” 11. 
As stated above, expression by DC of costimulatory molecules and secretion of cytokines is 
not sufficient to induce T cell activation. DC also need to be recruited to the appropriate sites 
in order to induce T cell responses. This implies migration of maturing DC from peripheral 
tissues towards the draining lymph nodes through lymphatic vessels (reviewed in 12) as well 
as mobilization of resident DC of the lymphoid organs to the T cell zones 13 or recruitment of 
DC, mostly immature, to the peripheral inflammatory tissues 14,15.  
We have previously shown in a human model that antigen specific interactions of CD4+ T 
cells with immature DC induce activation of DC leading to expression of co-stimulatory 
molecules and production of IL-12 10. We show herein that CC chemokines produced during 
these antigen specific interactions between CD4+ T cells and DC also induce specific 
attraction of immature DC to the site of interaction. This induced chemotaxis of immature DC 
 3
 personal use only.
For at CALIFORNIA INST TECH/MILLIKAN LIBRARY on January 24, 2008. www.bloodjournal.orgFrom 
is accompanied by a complete remodelling of the DC actin cytoskeleton, which leads to 
dissolution of adhesion structures known as podosomes 16 and to a drastic change of the 
morphology of DC. Actin cytoskeleton remodelling also depends on chemokines suggesting 
that the disappearance of podosomes and the acquisition of migratory ability by DC are 
linked.  
MATERIALS AND METHODS  
Reagents and antibody 
Medium: RPMI 1640 Glutamax, 1% pyruvate, 100 U/ml penicillin, 100 µg/ml streptomycin 
(Invitrogen), and 10% FCS (Biowest). Recombinant human IL-4 and GM-CSF were from 
BRUCELLS. Recombinant bacterial superantigens were from Toxin Technology. PTX and 
CCI were from Sigma-Aldrich, chemokines (CCL3, CCL4, CCL5, CXCL8) from R&D 
system. Mouse mAbs against human CD4, CD69, CD40, CD80, CD83, CD86 and isotypic 
controls coupled to fluorochromes were from BD Bioscience. Alexa 488-conjugated F(ab')2 
anti-mouse Abs, CFSE (Carboxy-fluorescein diacetate succinimidyl ester), DiD (Vybrant DiD 
cell-labeling solution) and phalloidin coupled to Alexa 543  were from Molecular Probes. 
 
Cells 
DC were generated from human monocytes of healthy donors as previously described 10. 
Briefly, anti-CD14+ monocytes were sorted positively using magnetic microbeads (Miltenyi 
Biotec). Monocytes were cultured 5 days in medium supplemented with 100 ng/ml GM-CSF 
and 50 ng/ml IL-4. This protocol lead to 98 to 99% of CD1a+/CD14- DC presenting an 
immature phenotype 10. CD4+ T cells were negatively selected from PBMCs, after depletion 
of CD14+ cells, using the T cell isolation kit II from Miltenyi Biotec. Sorted CD4+ T cells 
were 97–99% CD4+/CD3+. 
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Preparation of active supernatants 
1.5x105 DC were co-cultured with 3x105 T cells in 24-well plates in the presence or absence 
of superantigen. Supernatants were collected and filtered 24 hours later.  
 
T cell activation assay and flow cytometry analysis 
DC were left untreated or pre-treated with 200 ng/ml PTX for 2 hours, extensively washed 
and co-cultured overnight with CD4+ T cells in flat or round -bottom 96-well plates. 
Cells were stained with APC-coupled anti-CD69 and FITC-coupled anti-CD4 mAbs at 4°C 
for 30 min. Samples were analyzed on a FACSCalibur using the CellQuest software (BD 
Biosciences).  
 
Migration experiments 
Chemotaxis of DC was measured by migration through a polycarbonate filter of 5 µm pore 
size in transwell chambers (Corning Costar). 2x105 DC (150 µl) were seeded in the upper 
chamber, control medium or stimuli (250 µl of supernatants or recombinant chemokines at 
100 ng/ml) were added into the lower chamber. In some experiments, DC were pretreated 
with 200 ng/ml PTX (2 hours at 37°C) or CCI (20 minutes, room temperature) before the 
assay. After 2 hours at 37°C, 105 beads (Beckman Coulter) were added to all lower wells and 
the number of cells for a given number of beads counted by flow cytometry. Values are given 
as percentage of cells in the lower well ± SD.  
For the Dunn chamber analysis, both annular wells of the Dunn chamber were filled with 
control medium and the poly-L-lysin coated coverslip seeded with DC was inverted onto the 
chamber. A narrow filling slit at one edge was left to access the outer well. To set up a 
chemotactic gradient, medium was drained from the outer well and replaced with medium 
containing the chemoattractant. The slit was sealed with nail polish 17.  
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Cells were left for 20 to 30 min in the Dunn chamber before being visualized with a Leica 
DMI 6000 B under and 10X phase contrast objectives. Images were captured at 1 minute 
intervals and analyzed with Metamorph (Universal Imaging) software. Average rates of cell 
movement were calculated based on the total movement of cell centroid over the time of 
observation. 
Directionality of cell movement was analyzed using scatter diagrams of cell displacement. 
The diagrams are oriented so that the position of the outer well of the chamber is vertically 
upwards (y direction). Each line represents the trajectory of one cell during the recording 
period (90 minutes) where the starting point of the migration is fixed at the intersection of the 
two axes.  
 
Cytokine detection in the supernatant 
Chemokine secretion was measured in the supernatants by cytometric bead array (BD 
Biosciences). 
 
Flow cytometric analysis of chemokine production. 
DC were co-cultured overnight with CD4+ T cells in flat-bottom 96-well plates. Cells were 
then stained with APC-coupled anti-CD4 and Cy-Chrome-coupled anti-CD1a mAbs (BD, 
Biosciences). After surface labeling, cells were fixed, permeabilized, and stained for 
intracellular cytokine production with PE-coupled anti-CCL3, or anti-CCL 5 or FITC-coupled 
anti-CCL4 (R&D Systems). Isotypic controls were used as negative controls. Samples were 
analyzed on a FACSCalibur (BD Biosciences).  
 
Video imaging 
Videomicroscopy was performed using a Leica DM IRBE epifluorescence microscope 
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equipped with a x63, 1.32 numerical aperture objective, a cooled charge-coupled device 
camera (MicroMax, Princeton Instruments from movies 3, 4; Coolsnap EZ, Photometrics for 
movies 1, 2). Poly-L-lysin coverslips covered with DC were placed into a chamber on the 
microscope at 37°C in a 5% CO2 atmosphere. At time 0, T cells were added, and images were 
recorded every 3 minutes for 5 hours. Data acquisition and analysis were done with 
MetaMorph software (Universal Imaging). 
 
Confocal microscopy 
DC and T cells were co-cultured on coverslips. In some experiments, cells were stained with 
CFSE or DiD before culture according to manufacturer’s instructions.  
After co-cultures, cells were fixed with 3% paraformaldehyde (Carlo Erba) and incubated in 
PBS glycine (10 mM) to quench free aldehyde groups. Cells were then permeabilized with 
0.1% Triton, stained first with anti-vinculin Ab (Sigma) and then with Alexa 488-conjugated 
F(ab')2 anti-mouse Ig. F-actin was visualized using Alexa 543-conjugated phalloidin. 
Coverslips were mounted onto glass slides using Fluoromount-G (Southern Biotechnology 
Associates). Green and red fluorescence were acquired sequentially to prevent leakage of 
fluorescence from one channel into another.  
Images were collected using a Leica TCS SP2 confocal scanning microscope equipped with a 
x63, 1.4 numerical aperture oil immersion objective. All quantifications were performed 
blindly on 8-bit images using MetaMorph software. 
RESULTS 
Antigen specific contacts between CD4+ T cells and DC induce DC mobility and 
recruitment towards the sites of DC-T cell interaction. 
We followed by time-lapse videomicroscopy the first hours of interaction between human 
immature DC and CD4+ T lymphocytes. Immature DC were pre-incubated with a cocktail of 
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superantigens (TSST1+SEE+SEA+SEC+SED) and plated on glass coverslips. CD4+ T cells 
were then added and every 3 minutes a series of 4 xy planes contrast phase images was 
acquired for 5 hours. In the presence of CD4+ T cells alone, or superantigens alone, DC 
neither changed their morphology nor became mobile (Fig. 1 A and movies 1, 2). Moreover, 
as previously described 18, DC established few interactions with T cells in the absence of 
antigenic stimulation (Fig. 1 A, movie 1). In sharp contrast, in the presence of both T cells 
and superantigens, immature DC became mobile, as shown by movies and quantification of 
the images (Fig. 1 A and movie 3). This DC mobility was accompanied, after 2-3 hours of 
interaction with CD4+ T cells, by striking morphological changes of the DC, which acquired 
an elongated shape, extending and retracting long dendrites. Activated DC established 
contacts with CD4+ T cells but also with other DC, forming dynamic clusters of CD4+ T cells 
and DC.  
These results show that antigen-specific interactions between CD4+ T cells and DC induce 
mobility, morphological changes and clustering of DC.  
We then tested if the acquired DC mobility support their attraction to the site of ongoing DC-
T cell interactions. 
To do so, we designed an experiment to visualize the recruitment of immature DC to the sites 
of superantigen-specific DC-CD4+ T cell interactions. DC preparation were separated in two, 
one population was stained with the fluorescent lipid DiD and pulsed or not with TSST1 and 
the other was CFSE-labeled and was not exposed to superantigen. After extensive washing, 
both populations were seeded on coverslips. CD4+ T cells were then added.  Six hours later, 
coverslips were analyzed by confocal microscopy. Image quantification showed that in the 
absence of antigen about 10 % of DiD-labeled DC were in contact with CFSE-labeled DC, 
whereas in the presence of superantigen, the number of DiD-DC/CFSE-DC interactions was 
significantly increased (to 31%, Fig. 1B,C). These results show that neighboring immature 
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DC, which did not directly interact with T cells, are recruited to sites of antigen-specific DC-
CD4+ T cell interactions. 
 
Chemokines produced during superantigen specific DC-CD4+ T cell interactions induce 
chemotaxis of immature DC.  
We then asked if soluble factors produced during superantigen induced DC-CD4+ T cell 
interactions were sufficient to trigger DC mobility and morphological changes. Immature DC 
were exposed to supernatants from co-cultures of DC+ CD4+ T cells+ superantigens and 
followed by videomicroscopy. As shown in Fig. 2A and movie 4, DC became rapidly mobile 
and acquired an elongated morphology. This behavior was similar to that observed in the 
presence of T cells.  
We next performed experiments to test if the mobility induced by “active” supernatants was 
due to chemotaxis (directional movement of cells) or chemokinesis (random cell movement) 
using a Dunn chemotaxis chamber. This system allows to study the behavior of cells 
subjected to linear gradient of chemoattractants 17. Immature DC were exposed to gradients of 
“active” supernatants in the Dunn chamber and imaged by time-lapse videomicroscopy under 
phase contrast. Migration tracks of the DC were then quantitatively analyzed with a program 
developed in Matlab. Figure 2B shows cell trajectories from one representative experiment 
and direction of the gradient is represented by black lines (the gradient is radial, because of 
the geometry of the chamber). In figure 2D, the same trajectories are represented in a scatter 
diagram, with the gradient directed vertically upwards (y). 
We calculated the percentage of migrating immature DC, which ended up within a 120° arc 
facing the supernatant source. For totally random migration, we would expect to find 33% of 
the cells in this region. In contrast, when DC were exposed to a gradient of “active” 
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supernatant, 62.6%+2.3% of the DC were found within the 120° arc after 90 minutes of 
migration, showing a directional migration of DC towards the supernatant source. 
We further characterized the dynamic parameters of T cell-dependent DC migration by 
measuring the mean velocity of the DC in the Dunn chamber. In Fig. 2C, the radial and the 
horizontal velocity are plotted as a function of time. The radial velocity (Vr, component of the 
mean velocity along the gradient), is positive over time, and reaches 0.5 μm/min. In contrast, 
the values of the horizontal velocity (Vh, component perpendicular to the gradient), oscillate 
in a small range around zero, indicating that the horizontal cell displacement is random and 
limited. Control supernatants prepared from DC co-cultured overnight with T cells in the 
absence of superantigen did not induce any chemotaxis of DC (Fig. 2 D, middle panel).  
We then used Bordetella pertussis toxin (PTX), an inhibitor of Gαi protein-coupled receptors, 
which blocks all Gαi coupled chemokine-receptors, to test the involvement of chemokines. 
DC were pre-treated with 200 ng/ml PTX for 2h, and extensively washed before imaging their 
migration in the Dunn chamber. As shown in Fig. 2D, right panel, PTX pre-treatment of DC 
inhibited chemotaxis induced by “active supernatants”.  
To confirm that soluble factors secreted during T-DC contacts could promote immature DC 
migration, we performed transwell chemotaxis assays 19. Medium or supernatants from 
different co-cultures were placed in the lower chamber of the transwell system, and immature 
DC were added to the upper chamber. As presented in Fig. 2E, “active” supernatants induced 
significant migration of immature DC to the lower chamber, whereas supernatants from co-
cultures of DC+CD4+ T cells or of DC+superantigens alone did not. PTX treatment 
completely abrogated the “active” supernatant induced DC migration, confirming the results 
obtained in the Dunn chamber (Fig. 2E). Of note, mature DC obtained by overnight LPS 
treatment did not migrate towards “active” supernatants (Fig. 2E), whereas as previously 
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shown 20 they migrated towards CCL19 and CCL21 (data not shown), showing that “active” 
supernatants specifically induced the migration of immature DC. 
Altogether, these results demonstrate that chemokines produced during superantigen-specific 
interaction of CD4+ T cells with DC induce chemotaxis in immature DC, supporting the 
recruitment of fresh immature DC towards the site of T cell-DC specific interaction. 
 
CC chemokines produced by DC-CD4+ T cell conjugates induce migration of immature 
DC.  
We then studied which chemokines were produced in supernatants of CD4+ T cells cocultured 
with DC or DC pulsed with TSST1, by cytometric beads arrays. As shown in Fig. 3A, the 
following chemokines were secreted in the co-cultures of DC and T cells: CXCL8, CXCL9, 
CXCL10, CCL2, CCL3, CCL4, CCL5. Most of these chemokines were secreted only in the 
presence of superantigen. 
To better characterize which chemokines were involved in DC migration, we used vCCI 
(viral CC chemokine inhibitor), a viral component that specifically inhibits chemokine 
receptors belonging to the CC family 21,22. As expected, CCI inhibited DC migration towards 
CCL5, but not towards CXCL12 (supplemental Fig. 1). Pre-treatment of DC with CCI 
inhibited dose-dependently DC migration towards “active supernatants” (Fig. 3B) showing 
that CC-chemokines are involved in the migration of immature DC.  
We thus tested the CC chemokines present in the “active” supernatants for their ability to 
induce immature DC migration. As shown in Fig. 3C, CCL3, CCL4 and CCL5 induced 
migration of immature DC in the transwell assay.  
We then characterized the cell type(s) that produce(s) these 3 CC chemokines. Intracellular 
chemokine stainings were performed on CD4+ T cells and DC co-cultured overnight with 
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TSST1. As shown in Fig. 4, both DC and T cells produced CCL3 and CCL4, whereas CCL5 
was only detected in T cells.   
Altogether, these results demonstrate that CC-chemokines produced during antigenic 
stimulation by both CD4+ T cells and DC induce migration of immature DC. 
 
DC responses to chemokines enhance T cell activation. 
We then tested if DC responses to chemokines produced during superantigen induced 
interaction of CD4+ T cells with DC would influence T cell responses in return. To do so we 
cultured overnight CD4+ T cells together with untreated or PTX-pre-treated DC at different 
ratios in the presence of TSST1. We then followed CD69 expression by T cells (Fig. 5 A, B).  
When DC were pre-treated with PTX, the percentages of activated CD4+ T cells were 
significantly lower than the percentages obtained with untreated DC, for DC/T cell ratios < 
1/2, indicating that DC response to chemokines increases T cell activation. In contrast, for 
DC/T ratio >1/2, PTX treatment of DC had not significant effects, suggesting that DC 
response to chemokines is less critical at high cell concentration. 
To confirm our interpretation, we performed similar experiments in round bottom wells, 
wherein contacts between cells are forced by the geometry of the well. Under these 
conditions, PTX pre-treatment of DC did not affect T cell activation.  
We have previously shown that DC cocultured with CD4+ T cells and superantigen expressed 
higher amount of CD40, CD80, CD83 and CD86 10. This enhanced expression of 
costimulatory molecules may influence T cell activation. We thus tested if PTX pretreatment 
of DC inhibited the T cell driven DC maturation. As shown in Fig. 5 C, PTX treatment did 
not inhibit DC maturation, demonstrating first that PTX does not grossly perturb DC function 
and second that the inefficiency of PTX pretreated DC to activate T cells is not due to a lesser 
ability to mature.  
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Since T cells are highly sensitive to PTX, we controlled that PTX-treated DC did not release 
PTX in the supernatants, which could directly affect T cell activation. We thus added 
overnight supernatants from PTX-pretreated DC to co-cultures of untreated DC+CD4+ T 
cells+TSST1. These supernatants did not inhibit T cell activation (Fig. 5B grey histograms), 
showing that PTX was not released in the medium. We also tested if direct contact of PTX-
pre-treated DC with T cells could affect T cell migration. PTX pre-treated DC were thus 
added to the upper well of a transwell together with T cells and migration towards CXCL12, 
which has been shown to be PTX sensitive 23, was measured after 4h30. T cell migration 
towards CXCL12 was not affected by PTX treated DC (Fig. 5D).  
Overall our results strongly suggest that chemokine-induced DC modification plays a role in 
T cell activation.  
 
The actin cytoskeleton of immature DC is modified by cognate interaction with CD4+ T 
cells, and this depends on chemokines. 
As shown in Fig. 1 and movies 3 and 4, the T cell-induced mobility of DC was accompanied 
by striking morphological changes of the DC. To further characterize these changes and gain 
some insights into the mechanisms involved in mobility of immature DC, we studied the 
modifications of the DC cytoskeleton induced by CD4+ T cells. Since podosomes have been 
involved in DC mobility 24,25, we followed these structures in DC exposed to CD4+ T cells in 
the presence or absence of superantigen. When plated on glass coverslips, most immature DC 
presented the characteristic podosomes, composed of an actin core surrounded by vinculin, on 
their ventral face (80%, mean of 4 independent experiments, Fig. 6 A). The percentage of DC 
presenting podosomes drastically decreased from 80% to 20% in DC exposed to antigen 
specific interaction with CD4+ T cells. Moreover, when exposed to T cells in the presence of 
superantigen, DC showed an organization of the polymerized actin in filaments and actin 
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enrichment at the contact with T cells (Fig. 6A).  
We then studied the cytoskeleton of immature DC treated for 6 hours with “active” 
supernatants. As shown in Fig. 7A and quantified in 7B, the percentage of DC presenting 
podosomes was drastically reduced in DC submitted to “active” supernatants (28% vs 75%).  
We then examined the role of chemokines on this striking remodelling of the actin 
cytoskeleton. As shown in Fig. 6 and 7, pre-treatment of DC with PTX inhibited podosomes 
dissolution induced by T cells  (Fig 6 A, B) or “active” supernatants (Fig.7 A, B), strongly 
suggesting that chemokines are involved in the modifications of DC cytoskeleton induced by 
T cells. To confirm the role of chemokines in these modifications, we treated immature DC 
with several CC-chemokines and studied the modification of the cytoskeleton. As shown in 
Fig. 7A and quantified in Fig. 7C, CCL3 and CCL4 induced podosome dissolution and 
morphological changes in immature DC that were very similar to the modifications observed 
with the “active” supernatants.  In contrast, CXCL8, which binds CXCR1 expressed by 
immature DC (data not shown), did not significantly decrease the number of DC presenting 
with podosomes (Fig. 7C).  
Some chemokines have been shown to induce DC maturation 26-28 and DC maturation has 
been shown to induce podosome dissolution 25,29. We thus tested if CCL3 and CCL4, which 
induced podosomes dissolution (Fig. 7A and 7C), also induced DC maturation. As shown in 
Fig. 7D, no increase of CD86, CD83, CD80 and CD40 expression was observed, although as 
shown in Fig. 5C “active” supernatants did induce increased expression of these markers. 
These results show that podosome disassembly induced by CC chemokines does not require 
DC maturation.   
Altogether, these results demonstrate that chemokines produced during antigen-specific 
interaction between CD4+ T cells and DC induce actin cytoskeleton remodelling in immature 
DC, leading to podosome dissolution. 
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DISCUSSION 
DC are key cells in the regulation of T cell responses. Their efficiency depends on their state 
of activation, which regulates DC ability to process antigen and to express costimulatory 
molecules and cytokines 1. Activation of DC also controls DC migration to the appropriate 
sites, in tissues or lymphoid organs, wherein they prime T cells 30,31. CD4+ T cell dependent 
signals have been shown to play a crucial role in DC activation by inducing their licensing to 
prime CTL or their ability to polarize TH cell responses (reviewed in 32,33).  CD4+ T cell-
dependent signals induce expression by DC of co-stimulatory markers as well as production 
of cytokines 8-10. Regulated migration of DC, implying both migration of DC from the 
periphery to the T cell zones of lymphoid organs and migration inside the tissues or lymphoid 
organs, is central to the induction of physiological immune responses and probably to the 
maintenance of tolerance 34,35.  We thus addressed the question of the potential modulation by 
human CD4+ T cells of DC migratory ability.   
We show herein that CC chemokines produced at sites of CD4+ T cell-DC interaction induce 
recruitment of immature DC and formation of DC clusters at these sites. Some of these CC 
chemokines are produced both by DC and CD4+ T cells (Fig. 4), suggesting that both cell 
types contribute to the attraction of immature DC to the site of interaction.  
Since the chemokine receptors CCR1, CCR2, CCR3, CCR5 and CCR6 are expressed by 
immature DC 36,37, they may be involved in the chemotaxis we report herein. CCR6 can be 
excluded since its ligand CCL20 did not induce migration of immature DC (data not shown). 
The role of CCR7 can also be excluded since, as reported by others 37, the immature DC we 
used in this study did not express any mRNA for CCR7, even 4h after exposure to the 
supernatants and did not migrate towards CCL19 or CCL21 (data not shown). It is worth 
noting that the chemokines present in our conditioned supernatants did not induce any 
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migration of LPS-matured DC (Fig. 2E), showing that chemokines produced during antigen 
specific interaction of DC with CD4+ T cells specifically induced mobility of immature DC.  
Time lapse and confocal microscopy images of DC, that have been interacting for 6 to 18h 
with T cells in the presence of superantigens, show striking changes of the DC morphology, 
which correlated with the acquisition of their migratory ability. In these conditions, 25 to 30% 
of the immature DC elongated, changing from a roundish shape of 10-15 μm in diameter to a 
“neuron-like” shape of 50-80 μm in length. These modifications were also CC chemokine-
dependent and were not observed when immature DC were exposed to LPS or poly IC (data 
not shown) although these TLR ligands induced non-polarized extension of thin transient 
dendrites around the cellular body of DC. These elongated DC established contact with both 
CD4+ T cells and other DC  (Fig. 1, 6 and 7) and tended to form a network of interdigitating 
DC after 4 to 6 h of antigen specific contact with T cells. This chemokine-induced DC-DC 
interaction may favor the transfer of material between DC, which has recently been shown to 
amplify T cell responses 38.  
Morphological changes observed in immature DC were accompanied by striking 
modifications of the actin cytoskeleton. As previously reported 29,39, the majority of immature 
DC displayed big clusters of podosomes on their ventral face. When co-cultured with CD4+ T 
cell and superantigen or with “active supernatants”, DC showed actin filaments along the 
plasma membrane, as well as polymerized actin-rich “cups” in the contact zones with T cells, 
but only sparse podosomes on both ends (Fig. 6 and 7). Podosomes are highly dynamic 
structures consisting of a dense actin core surrounded by a ring of vinculin found on several 
cells from the myeloid lineage 40. These structures have been shown to be involved in cell 
migration, tissue invasiveness 41 and diapedesis 42. We show herein a strong inverse 
correlation between the presence of podosomes and DC migration. Indeed, as reported by 
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others, podosomes expressed by immature DC may restrict their speed of migration by 
increasing their interaction with the substrate 25.  
In our study, we show for the first time that chemokines, which induce DC migration, also 
induce podosome disassembly. Several maturation-inducing agents such as LPS 29,43, PGE2 
and  TNF-α 25,  have been shown to induce podosome dissolution suggesting that this 
dissolution is an integral part of the DC maturation process. Results reported herein suggest 
that these two phenomena can be dissociated since PTX pretreatment of DC blocks podosome 
dissolution but does not affect phenotypic DC maturation (Fig. 5C), whereas CC chemokines 
induce podosome dissolution without inducing DC maturation (Fig. 7D).  
Yet, the resulting redistribution of the actin pool trapped in podosomes towards different sites 
may be required for mature DC functions, such as the maturation of endosomes 44 or the 
recruitment of transmembrane receptors to the contact zone with interacting T lymphocytes 45.   
Chemokines can enhance and modulate T-cell activation by DC in more than one fashion. DC 
presentation of cognate antigen to CD4+ T cells in lymph nodes induces the local production 
of CCR5 ligands, which attract CD8+ T cells nearby DC-CD4 conjugates, thus facilitating T 
cell help 46. Chemokines also modulate T cell response independently of their chemoattractant 
activities 47, i.e. they bind DC membranes inducing T cell adhesion 48 and may induce DC 
maturation 26-28. Our data suggest that chemokines produced during DC presentation of 
cognate antigen to CD4+ T cells may also increase T cell response by modifying immature 
DC.  
Indeed, at low cell density PTX-pretreated DC are less efficient than untreated DC at inducing 
T cell activation (Fig. 5). This lower ability of PTX-treated DC to induce T cell activation 
may be due to their inability to spread (Fig. 6 and 7), thus offering less surface of contact with 
T lymphocytes. Alternatively, it may be due to their defective mobility. This decreased 
activation of CD4+ T cells was not due to “by stander” effect of PTX released in the medium 
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on T cells (Fig.5 B and D). Moreover, it was not due to an absence of secretion of chemokines 
known to attract T cells, since the same amount of CCL3 and CCL4 was present in 
supernatants from cocultures of PTX-treated DC or untreated DC with CD4+ T cells and 
superantigen (data not shown). Finally, it was not related to an inhibitory effect of PTX on 
DC maturation since PTX-treated DC or untreated DC co-cultured with T cells and 
superantigen show a comparable increased expression of CD40, CD80, CD83 and CD86 (Fig. 
5C).  
Altogether, our data suggest the following model: antigen specific interaction between CD4+ 
T cells and DC induces the secretion of chemokines by both cell types. This will attract more 
immature DC, providing a source of “fresh” non exhausted DC that still have the ability to 
capture antigen and produce IL-12. These findings may be physiologically relevant in 
different settings. First in inflammatory tissue, Ag-specific interactions of memory or effector 
T cells with DC will induce production of chemokines and cytokines that will attract and 
induce maturation of surrounding or circulating immature DC. These newly recruited DC will 
capture the Ag (from the environment or from the mature DC) migrate to the draining lymph 
node and constitute a new pool of Ag-presenting DC. Second, in the secondary lymphoid 
organs recruitment of some of the numerous resident DC to sites of antigen-specific DC-T 
cell interaction may be crucial for the inter-DC Ag transfer recently reported 38. This transfer 
of Ag to resident DC would be induced by T cell-signals and accompanied by a T cell 
dependent maturation of these resident DC that are mostly immature at the steady state 49. 
This would in turn increase T cell activation by amplifying Ag presentation through a larger 
network of resident DC. Our data are compatible with such a model since as shown herein, 
chemokines produced by antigen specific DC-CD4+ T cell conjugates induce mobility of DC 
as well as direct contact between DC potentially enabling transfer of material between DC. 
Third, even in the absence of Ag transfer between DC, efficient self presentation by newly 
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recruited resident DC that will also receive T cell-derived activation signal may increase the 
activation of T cells responding to limiting amount of foreign antigen 50. 
We are currently developing in vivo models to test these hypotheses. 
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LEGENDS 
 
Figure 1. DC mobility increases after contact with T cells and superantigen (Sag). DC 
(105) were exposed to Sag, and seeded on polylysin-coated coverslips. T cells were added 
(3x105) before image recording. Images were recorded every 3 minutes for 5 hours. (A) Still 
images taken from web movies 1, 2 and 3 (DC+T cells, DC+Sag, and DC+T+Sag, 
respectively). Arrows point individual DC. Bar, 20 μm. Right panels, mobility tracks of all 
DC present in the fields from movies 1, 2, 3 are shown. Results are representative of 3 
experiments. (B,C) DC are recruited to the sites of DC-CD4+T cells interaction. DC stained 
with DiD (red)  pulsed with TSST1 (+Sag) or left unpulsed (-Sag), were seeded on coverslips 
together with unpulsed immature CFSE-labeled DC (green) and CD4+ T cells and cultured for 
6h. Cells were then fixed and coverslips mounted for confocal microscopy. (B) 
Representative images are shown. Bar, 40 μm (C) Percentages of DiD-DC in contact with 
CFSE-DC. Results represent mean + SD of 3 independent experiments (30 to 40 conjugates 
analyzed per experiment). Significance assessed by Student’s unpaired t test (** p<0.005).  
 
Figure 2. Chemokines produced during DC-T cell interactions induce DC chemotaxis. 
(A,B) DC are seeded on coverslips and exposed to supernatants from 24h-cocultures of DC+T 
cells+Superantigens. Videomicroscopy was performed as in Fig.1. (A) Individual frames from 
web movie 4 and corresponding DC mobility tracks are shown, representative results of 4 
experiments. Bar, 20 μm. (B, C, D) Dunn chamber assay. (B) Migration tracks of DC in a 
gradient of supernatant from DC+T cells+Superantigens (one representative experiment). DC 
individual trajectories in the chamber are represented in colors and direction of the gradient is 
figured with black lines. (C) Mean horizontal and radial velocity of DC. (D) DC trajectories 
are plotted in a scatter diagram with the starting point for each cell at the intersection between 
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the X and Y axes, and the direction of the gradient vertical upwards. Left panel: DC exposed 
to “active” supernatants as in B. Percentage of cells that ended up within a 120° arc facing the 
supernatant source is indicated (mean + SD of 3 independent experiments with ≥ 400 cells 
tracked). Middle panel: DC exposed to supernatant from DC+T cells. Right panel: PTX 
treated DC exposed to “active” supernatant. (E) Transwell chemotaxis assays. Untreated 
immature DC or DC treated with PTX (DCPTX) or LPS-treated DC (DCm) were placed in the 
upper chamber of a transwell, and supernatants from the indicated 24h-cocultures in the lower 
chamber. Percentages of DC attracted to the lower chambers  after 2 hours are shown. Data 
are mean + SD of 3 independent experiments. 
 
Figure 3. DC migration is induced by CC-chemokines. (A) Chemokines secreted in the co-
cultures of DC+T cells with or without TSST1 are quantified by cytometric bead arrays. Each 
dot represents one donor, mean of chemokine secretion is indicated in each column. (B) CCI 
inhibits DC migration. DC were pretreated with different concentrations of CCI and migration 
towards the active supernatant analyzed. Percentages (mean+SD) of neutralization of DC 
migration is calculated as follows 100- ((% of CCI-treated DC in lower chamber/ % of 
untreated DC in the lower chamber) X 100).       
(C) Percentage of DC attracted towards different recombinant chemokines in transwell 
chambers are shown. Mean + SD of triplicates from one representative experiment. 
 
Figure 4. Production of CC-chemokines by DC and CD4+ T cells. DC and CD4+ T cells 
were co-cultured with or without TSST1 (Sag) for 24h. FACS analysis was performed to 
detect intracellular chemokine production (CCL3, 4 and 5) in DC gated on CD1a expression 
and CD4+ T cells gated on CD4 expression. Percentage of DC or T cells producing 
chemokines are indicated in each panel. One representative experiment out of 3. 
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Figure 5. Pertussis toxin-treated DC are impaired in the ability to activate CD4+ T cells. 
(A,B) 4x104 CD4+T cells were incubated with DC, pulsed with 100 ng/ml of TSST1, pre-
treated (+ PTX) or not (- PTX) with  PTX. CD69+ expression on CD4+ T cells was analyzed 
by FACS. (A) Histograms of CD69 expression on CD4+ T cells co-cultured with DC at a 
DC/T ratio of 1/4 in round or flat bottom wells, % of CD69+/CD4+ T cells are indicated. (B) 
For each DC/T cell ratio, data were normalized to the percentage of CD69+/CD4+ T cells 
obtained in the co-cultures of untreated DC (=100%).  Mean and SD of 3 experiments. For the 
indicated ratio, overnight-supernatants from PTX-pretreated DC were added to the co-cultures 
(grey histograms) (C) Flow cytometric analysis of DC maturation markers in the flat bottom 
co-cultures. (D) CD4+ T cells were added to the upper chamber of a transwell system together 
with untreated or PTX-treated DC (DCPTX) and migration towards CXCL12 was analyzed. 
Significance assessed by Student’s unpaired t test. (* p< 0.05; **,  p< 0.005). 
 
Figure 6. Ag specific interactions between CD4+ T cells and DC induce podosome 
dissolution in DC. (A) Untreated or PTX-treated DC were co-cultured with CD4+T cells on 
coverslips in the presence or absence of TSST1. Cells were then fixed and labeled with anti-
vinculin Ab (green) and phalloidin (red). Bar, 10 μm. (B) DC presenting podosomes were 
quantified, plotted to the total number of cells present in the field and presented as %. Mean + 
SD of 4 independent experiments, ≥ 25 total cells were examined for each condition in each 
experiment. Significance assessed by Student’s unpaired t test. (* p< 0.05; **,  p< 0.005). 
 
Figure 7. Chemokines induce podosome dissolution in DC. (A) Untreated or PTX-treated 
DC were exposed to the indicated supernatants, or to recombinant chemokines (CCL3, 
CCL4), and then labeled with anti-vinculin Ab (green) and phalloidin (red). Bar, 10 μm. (B, 
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 26
C) Cells presenting with podosomes were quantified as in Fig. 6. Mean + SEM of 4 
independent experiments, ≥ 25 total cells were examined for each condition in each 
experiment. Significance assessed by Student’s paired t test. (* p< 0.05). (D) Flow cytometric 
analysis of DC maturation markers in response to chemokines. 
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